- HOME
- News Release
2021
- Dec 27
-
- Publication of a Research Paper on 5-ALA from Tokyo Metropolitan University in FEBS Open Bio -5-ALA/SFC extend healthspan in Drosophila-
- (263.3 KB)
- Dec 11
-
- Notice Regarding the Results of the Tender Offer for the Shares of Shinsei Bank, Limited (Securities Code: 8303) and Changes in Subsidiaries
- (287.0 KB)
- Dec 10
-
- SBI Holdings, Inc. Responds to Media Reports
- (185.8 KB)
- Nov 26
-
- Notice Regarding Filing of Amendment to the Tender Offer Registration Statement for Share Tender Offer to Shinsei Bank, Limited, (Securities Code: 8303) and Extension of the Tender Offer Period
- (209.8 KB)
- Nov 24
-
- Notice Regarding the Tender Offer for Shinsei Bank, Limited, (Securities Code: 8303)
- (184.1 KB)
- Nov 12
-
- Notice Regarding Our Supplementary Explanation with regard to the Tender Offer in Response to Issuance of Proxy Advisors’ Reports concerning Takeover Defense Measures of Shinsei Bank, Limited. (Securities Code: 8303)
- (265.5 KB)
- Nov 12
-
- Notice Regarding Our Response to Questions from Deposit Insurance Corporation of Japan
- (455.2 KB)
- Nov 8
-
- Announcing the Launch of a Distributed Ledger Technology Based Money Transfer Service Between Thailand and the U.S. & Europe Regions in Partnership with Bank of Ayudhya
- (167 KB)
- Oct 28
-
- Interim Dividend for the Fiscal Year Ending March 31, 2022
- (147.8 KB)
- Oct 28
-
- Notice Regarding the Establishment of the Sustainability Committee
- (147.8 KB)
- Oct 21
-
- Notice Regarding the Opinion on the Tender Offer from Shinsei Bank, Limited. (Securities Code: 8303) and Procedures for Convocation of the Shareholders Meeting to Confirm Shareholders’ Intent
- (154.2 KB)
- Oct 12
-
- Results of A First-in-Human Study for New Application of Photodynamic Therapy with 5-Aminolevulinic Acid for Extracorporeal Photopheresis Published in “Pharmaceutics”
- (167.7 KB)
- Oct 11
-
- Notice Regarding the Forecast of the Consolidated Profit Before Income Tax Expense For the Six Months Ended September 30, 2021
- (132.0 KB)
- Oct 8
-
- Notice Regarding the Application for Listing of SBI Sumishin Net Bank, Ltd.
- (185.7 KB)
- Oct 1
-
- Notice Regarding Response from Shinsei Bank, Limited. (Securities Code: 8303) to the Questions from the SBIHD Parties
- (125.6 KB)
- Sep 29
-
- Notice of the Extension of the Tender Offer Period to Shinsei Bank, Limited. (Securities Code: 8303)
- (146.3 KB)
- Sep 28
-
- Notice Regarding Our Response to “Questions to SBI Holdings and SBI Regional Bank Holdings” from Shinsei Bank, Limited. (Securities Code: 8303)
- (527.6 KB)
- Sep 24
-
- Notice Regarding Our Response to “Request for Extension of End Date of Tender Offer Period” from Shinsei Bank, Limited. (Securities Code: 8303)
- (227.5 KB)
- Sep 9
-
- Notice Regarding Commencement of a Tender Offer for the Shares of Shinsei Bank, Limited (Securities Code: 8303)
- (480.4 KB)
- Sep 7
-
- Photonamic GmbH & Co. KG (Germany) Enrolls First Patient in Phase 2 Clinical Trial of PD L 506 (5-ALA HCl) for Interstitial Photodynamic Therapy (iPDT) of Glioblastoma
- (243.3 KB)
- Aug 13
-
- Notice of the Completion of SBI Capital’s Registration as a New Technology Venture Capital Company
- (171.6 KB)
- Aug 11
-
- Notice Regarding the Launch of a DLT-based Money Transfer Service between Korea and Thailand -Cooperating with Global Money Express Co., Ltd., a Major Korean Funds Transfer Service Provider-
- (164.2 KB)
- Jul 19
-
- Results of Phase II Trial for Breast Cancer Surgery Published in Breast Cancer Research
- (215.9 KB)
- Jul 19
-
- Research Article on Treatment with 5-Aminolevulinic Acid Phosphate for Patients with New Coronavirus Infection (COVID-19) Published in the International Academic Journal “The Open COVID Journal” Specialized in COVID-19
- (131.6 KB)
- Jul 7
-
- Notice Regarding Investment in AND Global, a Fintech Startup Originally from Mongolia
- (159.3 KB)
- Jul 7
-
- SBI Biotech’s Licensed product, an Anti-ILT7 antibody (HZN-7734) has achieved a Developmental Milestone in a Phase 2 Clinical Trial
- (99.7 KB)
- Jun 8
-
- The Group's Initiatives to Prevent Recurrence in Response to the Incident at SBI Social Lending
- (151.7 KB)
- May 12
-
- Notice of Joint Establishment of a Private Fund By FUJITEC and SBI Investment
- (171 KB)
- May 7
-
- SBI ALApharma Canada Inc., a Subsidiary of photonamic GmbH & Co. KG (Germany), Enrolls First Patient in Pivotal Phase 3 Clinical Trial of PD G 506 A (5-ALA HCl) and Eagle Fluorescence Imaging SystemTM for Breast Conserving Surgery
- (171 KB)
- Apr 28
-
- Notice Regarding Dividend of Surplus
- (184.6 KB)
- Apr 28
-
- Notice regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2023 and 2025
- (103.1 KB)
- Apr 16
-
- photonamic GmbH & Co. KG (Germany) Acquires Majority Stake in FerroSens GmbH.
- (93.9 KB)
- Mar 19
-
- SBI Crypto announces start of its Mining Pool Service
- (117.2 KB)
- Mar 8
-
- Start of Phase II Clinical Trial using 5-ALA by the University of Oxford and SBI Pharmaceuticals
- (108.4 KB)
- Mar 1
-
- New Release of “Aladuck 405”, Bicolor LED Medical Light Source
- (162.7 KB)
- Feb 12
-
- Subscription by Japannext Co., Ltd. to Third Party Allotment Capital Increase
- (156.7 KB)
- Feb 8
-
- Notice of Establishment of Investment Company in Korea
- (205.6 KB)
- Jan 29
-
- Notice of the Completion of Ripple's Investment in Money Tap Co., Ltd.
- (172.5 KB)
- Jan 14
-
- Notice Regarding Case Reports on Treatment with 5-Aminolevulinic Acid Phosphate for Patients with New Coronavirus Infection (COVID-19)
- (131.1 KB)
- Adobe Reader
You need to download Adobe Reader to view these PDF files.
- There is no charge for downloading Adobe Reader.
- The logos of Adobe Reader and Adobe Reader are the registered trademarks of Adobe Systems.
